Medical Organizations on the Insurance Market in Russia
DOI:
https://doi.org/10.61841/k3kn0013Keywords:
healthcare fraud, payment for treatment, medical intermediation, insurance product, opportunistic behavior.Abstract
Purpose – In order to confirm or disprove the hypothesis that medical organizations play the role of intermediaries on the market of insurance products we conducted a study about the nature of intermediation carried out on the market of insurance products, as well as the analysis of the activities of medical organizations and their impact on the development of the insurance market.
Design/Methodology/Approach – Using a systematic approach, structural-functional method, comparative and system analysis, visualization and generalization of the obtained results, we determined that medical organizations are the intermediaries on the market of insurance products. Medical organizations were not considered to be participants on the insurance products market. To fill this gap, it was hypothesized.
Findings – Perspectives were developed to improve the reliability of medical organizations as intermediaries on the medical insurance market; recommendations given; fraudulent actions of medical organizations observed; situation in Russian Federation is compared with number of other countries.
Practical Implications – The found development perspectives will reduce the risk of opportunistic behavior of medical organizations, which is often realized in voluntary health insurance. The reduction of tort risks for insurers that provide medical insurance will reduce the number of fraudulent payments, which will have a positive impact on the tariff policies of insurance companies and increase the reliability of the medical insurance market
Originality/Value – The aspects of intermediation of medical organizations are analyzed from the point of view of insurance theory.
Downloads
References
1. Adzhienko, V.L. and Kosinova, N.N. (2017). “Strategic analysis of the state-private partnership institute in the healthcare”, Pharmacy and Pharmacology, Vol. 5, No. 4, pp. 380-400. DOI: 10.19163/2307-9266-2017-5-4-380-400
2. Arrow, K.J. (1963). “Uncertainty and the Welfare Economics of Medical Care”, The American Economic Review, Vol. 53, No. 5, pp. 941-973.
3. Belozerov, S.A. and Motovilov, O.V. (2012). Banking: a textbook. (p. 408). Moscow: Prospectus.
4. Belozerov, S.A. and Pisarenko, Zh.V. (2014). “Testing the Russian insurance market for the presence of convergence”, Economy of the region, Vol. 3, pp. 198-208.
5. Dominique-Ferreira, S. (2018). The key role played by intermediaries in the retail insurance distribution. International Journal of Retail and Distribution Management, Vol. 46, No. 2, pp. 1170-1192. DOI: 10.1108/IJRDM-10-2017-0234
6. Dominique-Ferreira, S., Vasconcelos, H. and Proença, J.F. (2016). “Determinants of customer price sensitivity: an empirical analysis”, Journal of Services Marketing, Vol. 30, No. 3, pp. 327-340.
7. Dzhevaga, N. V., & Lobacheva, О. L. (2018). Separation of the rare-earth elements (REE) by flotation approaches. The International Multidisciplinary Scientific GeoConference Surveying Geology and Mining Ecology Management,SGEM 2018, 18 (5.1), pp. 801-808.
8. Eckardt, M. and Räthke-Döppner, S. (2010). “The Quality of Insurance Intermediary Services – Empirical Evidence for Germany”, The Journal of Risk and Insurance, Vol. 77, No. 3, pp. 667-701. https://doi.org/10.1111/j.1539-6975.2010.01361.x
9. Epifanova, E.V. (2013). “The social danger of crimes in the field of health insurance”, Leningrad legal journal, Vol. 4, No. 34, pp. 218-225.
10. Gomel, V.B., Mironkina, Yu.N. and Tulenty, D.S. (2013). “What does the insurer sell and buy the policyholder?” Insurance business, Vol. 1, pp. 30-36.
11. Gukov, A.V., Shor, I.M. and Shor, D.M. (2016). “Outsourcing in the activities of the insurance organization: opportunities and risks”, Financial analytics: problems and solutions, Vol. 36, pp. 55-66.
12. The Daily Star. (2015). Insurance Fraud in China growing. Available at: http://www.thedailystar.net/news/insurance-fraud-in-china-growing.
13. Insurance Information Institute. (2019, December 9). Background on: Insurance fraud. Available at: https://www.iii.org/article/background-on-insurance-fraud
14. Karan, A.K., Yip, W. and Mahal, A. (2017). “Extending health insurance to the poor in India: An impact evaluation of Rashtriya Swasthya Bima Yojana on out of pocket spending for healthcare”, Social Science & Medicine, Vol. 181, pp. 83-92. DOI: 10.1016/j.socscimed.2017.03.053
15. Keegan, C., Teljeur, C., Turner, B. and Thomas, S. (2016). “Switching insurer in the Irish voluntary health insurance market: Determinants, incentives, and risk equalization”, The European Journal of Health Economics, 17(7), 823-831. DOI: 10.1007/s10198-015-0724-7
16. Kozminykh, O.V. and Ostanin, V.A. (2017). “Classification of intermediaries in the market of insurance products, depending on the risks they generate”, Competitiveness in the global world: economy, science, technology, Vol. 3-1, No. 32, pp. 80-85.
17. Kulakov, V.V. (2013). “Modern problems of the insurance mediation institution in the Russian Federation”, University Bulletin, Vol. 4, pp. 120-127.
18. Kuznetsova, N.P., and Pisarenko, Zh.V. (2011). “Formation of the mechanism of insurance mediation in financial conglomerates”, Bulletin of St. Petersburg State University, Vol. 4, pp. 76-87.
19. Lobacheva, O. L., Berlinskii, I. V., & Dzhevaga, N. V. (2017). Thermodynamics of complexation in an aqueous solution of Tb(lll) nitrate at 298 K. Russian Journal of Physical Chemistry A, 91 (1), pp. 67-69.
20. Official site of Coalition against Insurance Fraud. Available at: http://www.insurancefraud.org/index.htm.
21. Official site of the Bank of Russia. Available at: https://www.cbr.ru
22. Official site of the Vademencum research center. Available at: https://vademec.ru/news/2017/03/28/dolya-moshennichestva-v-dms-dostigla-15/
23. Osadets`, S.S. (2002). Insurance: Textbook. ed. 2nd. (p. 599). Finance and Statistics, Moscow.
24. Picard, P., Wang, J. and Wang, K. (2019). “Collusion between Retailers and Customers: The Case of Insurance Fraud in Taiwan”, Working Papers hal-02045335, HAL.
25. Rashid K. Nadirov, Leila I. Syzdykova, Aisulu K. Zhussupova (2017). Copper smelter slag treatment by ammonia solution: leaching process optimization. Journal of Central South University, 24, 2799-2804
26. Roehrich, J.K., Lewis, M.A. and George, G. (2014). “Are public–private partnerships a healthy option? A systematic literature review”, Social Science & Medicine, Vol. 113, pp. 110-119. https://doi.org/10.1016/j.socscimed.2014.03.037
27. Rosenthal, E. (2017). Insurance policy. How an industry shifted from protecting patients to seeking profit. Available at: https://stanmed.stanford.edu/2017spring/how-health-insurance-changed-from-protecting-patients-to-seeking-profit.html
28. Rovner, J. (2019). “The complicated, political, expensive, seemingly eternal US healthcare debate explained”, BMJ, Vol. 367, art. l5885. doi: https://doi.org/10.1136/bmj.l5885
29. Savvina, N.E. (2015). “A new approach to the concept of 'insurance product'”, Finance and credit, Vol. 18, No. 642, pp. 52-60. Available at: https://www.fin-izdat.ru/journal/fc/detail.php?ID=65678
30. Stempel, J.W. (2009). “The 'Other' Intermediaries: The Increasingly Anachronistic Immunity of Managing General Agents and Independent Claims Adjusters”, Connecticut Insurance Law Journal, Vol. 15, pp. 599-721.
31. Wagner, E. (2019, November 19). Making Sense of FEHBP's New 'Indemnity' Plans. Available at: https://www.govexec.com/pay-benefits/2019/11/making-sense-fehbps-new-indemnity-plans/161396/
32. Zhao, K. (2017). “Social insurance, private health insurance and individual welfare”, Journal of Economic Dynamics and Control, Vol. 78, pp. 102-117. DOI: 10.1016/j.jedc.2017.03.004
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
